Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has…
karnottMarch 31, 2025
Throughout its 50-year history, Fred Hutch Cancer Center has distinguished itself as a leader in…
karnottMarch 28, 2025
Predictive technologies are transforming R&D, accelerating the development of high-quality medicines, and bringing life-changing treatments…
karnottMarch 28, 2025
A major contributor to poor sensitivity to anti-cancer kinase inhibitor therapy is drug-induced cellular adaptation,…
karnottMarch 27, 2025
Several federal, state, and city officials from Washington state and Seattle participated in a March…
karnottMarch 27, 2025
In a provocative new essay published in PLOS Biology, ISB Professor Sui Huang and colleagues…
karnottMarch 27, 2025
Dr. Andrew Stergachis: ‘We were able to precisely resolve the genetic and molecular basis of…
karnottMarch 26, 2025
The Institute of Translational Health Sciences is pleased to announce the Pilot Award recipients for…
karnottMarch 26, 2025
After raising $28.3 million, Bothell-based VerAvanti is expanding its footprint in the Seattle region. Founded…
karnottMarch 25, 2025
